Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Raily Aesthetic Medicine International Holdings Limited ( (HK:2135) ) is now available.
Raily Aesthetic Medicine International Holdings Limited reported its audited consolidated financial results for the year ended December 31, 2024. The company experienced a revenue increase to RMB 199,342,000 from RMB 189,384,000 in 2023. Despite the revenue growth, the company faced a net loss of RMB 63,263,000, which increased from the previous year’s loss of RMB 37,779,000. The increase in loss was attributed to higher other expenses and a share of loss from an associate and a joint venture. The results indicate challenges in managing costs and investments, impacting the company’s financial performance and market positioning.
More about Raily Aesthetic Medicine International Holdings Limited
Raily Aesthetic Medicine International Holdings Limited is a company incorporated in the Cayman Islands, operating in the aesthetic medicine industry. The company focuses on providing a range of aesthetic medical services and products.
YTD Price Performance: 1.82%
Average Trading Volume: 585,879
Technical Sentiment Signal: Buy
Current Market Cap: HK$62.39M
See more insights into 2135 stock on TipRanks’ Stock Analysis page.